Kazakhstan Drug Prices: Aimanagabetov Exposes Shocking Discrepancies

Kazakhstan Drug Prices Under Scrutiny: Aimanagabetov Highlights Irregularities Kazakhstan is facing scrutiny over its drug pricing system, as Deputy Aimanagabetov revealed significant discrepancies between domestic and international prices. During a recent parliamentary session, Aimanagabetov detailed instances where the cost of domestically produced drugs far exceeds their factory prices and those in neighboring countries. "The price of a particular domestic drug is four times higher than its factory price," Aimanagabetov stated, referencing a specific example. He also pointed to price differences compared to Kyrgyzstan and Russia, where similar drugs sell for significantly less. This disparity raises concerns about affordability and access to essential medications for Kazakh citizens. Aimanagabetov's comments have sparked calls for an investigation into the pricing practices of pharmaceutical companies and regulatory bodies. The government is now under pressure to address these concerns and ensure that essential medicines are accessible and affordable for all citizens. Further investigations are expected to shed more light on the extent of these pricing irregularities and the measures to be taken to rectify the situation.